In low- and middle-income countries, many people living with
diabetes struggle to get the care they need. These challenges range
from having medicine in stock at the pharmacy to a lack of trained
doctors and nurses who can effectively diagnose and treat
We know from experience that changing diabetes care for the better takes programmes and partnerships - no one organisation can solve the challenge alone.
For more than two decades, we've been partnering to bring solutions that help people access the diabetes care they need, no matter where they live.
The Changing Diabetes® in Children programme ensures care and life-saving insulin for children with type 1 diabetes in low- and middle-income countries. Working together with Roche, the International Society for Pediatric and Adolescent Diabetes (ISPAD) and the World Diabetes Foundation (WDF), we have established 208 clinics in 14 countries. Today, Changing Diabetes® in Children is providing medical care and insulin to more than 26,000 children. By 2030, we aim to expand the programme to reach 100,000.
Since 2018, we have had a partnership with the International Committee of the Red Cross , the to tackle the growing need to improve chronic disease treatment. Our joint effort is anchored in a collective vision that all people living in humanitarian crises should have access to the healthcare they need. This partnership enables us to move quickly in times of crisis.
皇冠hg0088开户官网As a COVID-19 emergency response Novo Nordisk offers free insulin and shipment to our Red Cross partners and the humanitarian organisations we normally supply insulin to until October 2020.
In 2018, the Defeat-NCD Partnership was established to support
countries’ efforts to both prevent and treat chronic disease. The
public–private–people partnership is hosted by the United Nations
Institute for Training and Research (UNITAR) and includes
governments, multilateral agencies, civil society, academia,
philanthropic foundations and the private sector.
皇冠hg0088开户官网For many of these patients, living with diabetes becomes a daily struggle to cover the cost of treatment and basic necessities like housing, food and transportation.
Our Base of the Pyramid programme aims to ease the cost burden related to both medicines and healthcare. Initiated in 2010, the programme is working through local health authorities and health care organisations in four African countries.